Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Qiagen N.V.

QGENNYSE
Healthcare
Medical - Diagnostics & Research
$40.60
$-0.52(-1.26%)
U.S. Market opens in 8h 24m

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.4B
P/E Ratio19.99
EPS (TTM)$2.04
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$43.11
3 Months$50.86
1 Year Target$50.39

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 20.33, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $50.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.99 and a market capitalization of 8.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.26%
5-Day Change
-11.57%
1-Month Change
-19.46%
3-Month Change
-10.22%
6-Month Change
-10.34%
Year-to-Date (YTD) Change
-14.65%
1-Year Change
4.37%
3-Year Change
-13.17%
5-Year Change
-17.86%
All-Time (Max) Change
1950.51%

Contact Information

31 77 355 6600
Hulsterweg 82, Venlo, NaN, 5912 PL

Company Facts

57,000 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions